Showing results (1-10 of 198) with videos related to
Sort By:
Pageof 20
Pediatric Endocrinology Reviews : PER|July 18, 2013
Fibrous dysplasiaSteven A Lietman, Michael A LevineJournal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 28, 2010
SH3BP2 mutations potentiate osteoclastogenesis via PLCγSteven A Lietman, Lihong Yin, Michael A LevineBiochemical and Biophysical Research Communications|April 29, 2008
SH3BP2 is an activator of NFAT activity and osteoclastogenesisSteven A Lietman, Lihong Yin, Michael A LevineThe Journal of Bone and Joint Surgery. American Volume|November 3, 2005
A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasiaSteven A Lietman, Changlin Ding, Michael A LevinePediatric Endocrinology Reviews : PER|November 21, 2007
Genetic and molecular aspects of McCune-Albright syndromeSteven A Lietman, William F Schwindinger, Michael A LevineCurrent Opinion in Pediatrics|July 6, 2010
Hypercalcemia in children and adolescentsSteven A Lietman, Emily L Germain-Lee, Michael A LevineThe Journal of Clinical Endocrinology and Metabolism|December 20, 2007
Preimplantation genetic diagnosis for severe albright hereditary osteodystrophySteven A Lietman, James Goldfarb, Nina Desai, et al.Clinical Orthopaedics and Related Research|May 3, 2005
Reduction in Gsalpha induces osteogenic differentiation in human mesenchymal stem cellsSteven A Lietman, Changlin Ding, David W Cooke, et al.Human Mutation|June 21, 2006
Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activationSteven A Lietman, Natasha Kalinchinko, Xichao Deng, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 31, 2011
Decreased SH3BP2 inhibits osteoclast differentiation and functionTeruya Kawamoto, Chun Fan, Robert J Gaivin, et al.Pageof 20